Access cutting-edge covid-19 treatment through this clinical trial at a research site in Sacramento. Study-provided care at no cost to qualified participants.
Access covid-19 specialists in Sacramento at no cost
This study follows strict safety protocols and ethical guidelines
All study-related covid-19 treatment provided free
This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who are non-hospitalized or are hospitalized for observation but do not require supplemental oxygen for COVID-19.
Sponsor: Pfizer
Check if you qualify for this covid-19 clinical trial in Sacramento, CA
If you're searching for covid-19 treatment options in Sacramento, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Sacramento research site is actively enrolling participants for this clinical trial. You'll receive care from experienced covid-19 specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.